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doi:10.1016/j.ejvs.2010.09.006Abstract Background: Vulnerable carotid plaques are associated with cerebrovascular
ischaemic events. High-resolution magnetic resonance (MR) imaging not only allows the
morphological assessment of such plaques, but also provides geometrical data, which can be
used for biomechanical stress analysis. We assess its utility to assess the plaque stress profiles
of symptomatic (transient ischaemic attack (TIA) and non-disabling stroke) and asymptomatic
patients.
Methods: A total of 70 consecutive patients with confirmed underlying carotid artery disease
underwent carotid MR imaging of their carotid artery in a 1.5-T MR system using a standard
carotid atheroma imaging protocol. MR images were manually segmented for different plaque
components and used for biomechanical stress analysis. The maximum critical stress
(M-CStress) for various clinical groups was determined and compared.
Results: M-CStress of symptomatic plaques (n Z 45) was significantly higher than for asymp-
tomatic plaques (n Z 25) (median (interquartile range (IQR): 275 kPa (190e390) vs. 165 kPa
(120e200), p Z 0.0001)). Within the symptomatic group, no M-CStress differences were
present between the TIA (n Z 30) and stroke (n Z 15) patients (260 kPa (190e370) vs.
295 kPa (200e510), p Z 0.31). Within the TIA patient cohort, those who had presented with
recurrent TIAs (nZ 6) had significantly higher stresses than patients who had suffered a single
episode (n Z 24) (425 kPa (285e580) vs. 250 kPa (180e310), p Z 0.001).x 218, Level 5, University Department of Radiology, Addenbrooke’s Hospital, Hills Road, Cambridge
.
(U. Sadat).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
84 U. Sadat et al.Conclusions: Symptomatic carotid plaques, particularly those associated with recurrent TIAs,
have high biomechanical stresses. As there is pre-existing evidence to suggest that high biome-
chanical stresses are associated with plaque vulnerability, MR-imaging-based stress analysis
has the potential to identify high-risk patients with vulnerable plaques.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Vulnerable carotid plaques are associated with ischaemic
cerebrovascular events.1 The UK National Stroke Strategy
recommends urgent management of patients who have
suffered a cerebrovascular ischaemic event, suggesting
high-resolution carotid artery magnetic resonance (MR) or
computerised tomographic imaging within 48e72 h of the
event2 and, preferably, carotid intervention as the risk of
a recurrent event is high during this period.3 The Carotid
Endarterectomy Trialists Collaboration (CETC) report4
favours carotid endarterectomy (CEA) within 2 weeks of
the acute event, suggesting an annual risk reduction (ARR)
of 23% for the severe stenosis (70e99%) group and a higher
ARR of 14.8% for the moderate carotid stenosis (50e69%)
group.3 The benefit would otherwise decline up to 12 weeks
for the moderate stenosis group after which CEA confers no
benefit.5 High-resolution carotid MR imaging can prove
useful in identifying high-risk patients with vulnerable
plaques, who could benefit maximally from urgent carotid
intervention. This is because MR imaging is capable of
reliably identifying features of plaque vulnerability.6e8 It is
also capable of providing morphological information, which
can be used for the biomechanical assessment of pla-
ques.9,10 The biomechanical analysis of carotid plaques is
important for their vulnerability assessment as these pla-
ques are usually located in a dynamic environment of
carotid bifurcation where biomechanical stresses have
been observed to increase plaque vulnerability.11e13 The
biomechanical assessment of plaques has shown differ-
ences between stress profiles of symptomatic and asymp-
tomatic plaques14 and also in subgroups of symptomatic
plaques.15 Recently, we have demonstrated that high
biomechanical structural stresses are associated with
subsequent cerebrovascular events in mild-to-moderate
carotid stenosis patients.16 As biomechanical stress analysis
of plaques incorporates information about plaque
morphology, material properties of various plaque compo-
nents and local haemodynamic factors, it has the potential
of providing a comprehensive assessment of the vulnera-
bility status of plaques for the identification of high-risk
patients. In this study, we perform biomechanical stress
profiling of plaques from patients who had suffered tran-
sient ischaemic attacks (TIAs) or minor strokes and compare
it to that of asymptomatic plaques.
Methods
A total of 70 patients with underlying carotid artery disease
were recruited for this study. Twenty-five consecutive
patients were asymptomatic, that is, they either never had
any symptoms (true asymptomatic) in the past or had been
asymptomatic for more than 6 months. As many as 45
consecutive patients were symptomatic, that is, they had
suffered focal neurological symptoms (TIA or minor non-disabling stroke) attributed to underlying extracranial
carotid artery disease. The neurological assessment was
done by experienced stroke physicians. A retinal TIA was
defined as a partial or complete visual field loss in one eye
of ischaemic origin lasting less than 24 h, with a hemi-
spheric TIA being defined as a focal cerebral dysfunction of
ischaemic origin lasting less than 24 h.17 A recurrent TIA
was defined as a recurrence of retinal and/or hemispheric
TIA symptoms. A minor stroke was defined as a neurological
dysfunction of ischaemic origin with deficits persisting
longer than 24 h but with a Rankin score 3. The study
protocol was reviewed and approved by the regional
research ethics committee and all patients gave written,
informed consent.
The inclusion criteria for this study were:
 Internal carotid artery stenosis of 30e99% on duplex
ultrasound imaging during screening assessment; and
 Sufficient MR image quality to identify the lumen wall
and outer boundary of the arterial wall. (The image
quality (IQ) was rated before review by using a previ-
ously published 5-point scale18,19; images with IQ >3
were included for morphological analysis.)
Exclusion criteria included:
 previous CEA;
 cardiac arrhythmias;
 known coagulation/clotting disorder responsible for
patient’s symptoms;
 patients undergoing thrombolysis following the acute
cerebrovascular event; and
 clinical contraindications to MR imaging.High-resolution multi-contrast MR imaging
High-resolution carotid MR imaging of the research subjects
was performed in a 1.5-T MR imaging system (Signa HDx GE
Healthcare, Waukesha, WI, USA) with a four-channel
phased-array neck coil (PACC, Machnet BV, Elde, the
Netherlands). For symptomatic patients, this was done
within 72 h of the acute event to identify biomechanical
features of plaques nearer to the time of symptom onset.
Movement artefact was minimised using a dedicated
vacuum-based head-restraint system (VAC-LOK Cushion,
Oncology Systems Limited, UK) to fix the head and neck in
a comfortable position and allow close apposition of the
surface coils. After an initial coronal localiser sequence,
axial two-dimensional (2D) time-of-flight (TOF) MR angiog-
raphy was performed to identify the location of the carotid
bifurcation and the stenosis on either side. Axial images
(3 mm apart) were then acquired through the common
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cation to a point 12 mm (four slices) distal to the extent of
the stenosis identified on the TOF sequence. This method
ensured that the entire carotid plaque was imaged.20
The following electrocardiography (ECG)-gated fastspin
echo pulse sequences were used to delineate various pla-
que components such as fibrous cap (FC), lipid content and
plaque haemorrhage (PH): T1 weighted (repetition time/
echo time: 1  RR7.8 ms1) with fat saturation, proton
density (PD) weighted (repetition time/echo time:
2  RR7.8 ms1) with fat saturation, T2 weighted (repeti-
tion time/echo time: 2  RR100 ms1) with fat saturation;
and short tau inversion recovery (STIR) (repetition time/
echo time/inversion time: 2  RR46 ms1 150 ms1).21 The
field of view was 10  10 cm and matrix size 256  256. The
in-plane spatial resolution achieved was of the order of
0.39  0.39 mm.
Plaque components, that is, outer and inner arterial
wall, lipid content, fibrous tissue, PH and calcification were
manually delineated by an experienced MR reader (US) and
confirmed by a consultant radiologist (JHG) using a speci-
alised plaque segmentation software, CMR Tools (London,
UK), using previously published criteria.6,22 Following pla-
que segmentation, the plaque contours were used for 2D
mesh generation (Figs. 1 and 2). Cubic B spline technique
was used for smoothing the plaque contours.
Biomechanical stress modelling
The investigator responsible for the entire computational
analysis (ZT) were not involved in the acquisition of MR data
and image segmentation and not aware of the patient
groups.Figure 1 A, B and C showing symptomatic plaque of a transient is
weightings. L indicates lumen; yellow star indicates lipid conten
hypointense on STIR weighted images. D shows the contours as exp
fine mesh generated for simulations measuring <0.1 mm for the pla
lumen boundary to avoid simulation artefacts. F shows the band pl
(maximum critical stress) at the vulnerable site.A pre-shrink process for in vivo data
The in vivo MR images were obtained in diastole by cardiac
gating. A pre-shrink process was used to obtain the zero-
pressure geometry for each patient. It was used as the
numerical starting geometry to recover the in vivo geometry
when pressure was imposed in the lumen. The details of this
method have been published earlier.2,23 The average inner
circumferenceshrinkagewas9.701.80% for the70patients.
Mesh generation, computational models and solution
methods
The computational mesh was made and the model was
solved using ADINA 8.6 (ADINA Inc., MA, USA). All plaque
components including fibrous tissue, PH, lipid content,
calcification and healthy arterial wall were assumed to be
non-linear, isotropic, incompressible and hyperelastic. The
modified MooneyeRivlin strain energy density function was
used to describe the material.24 Material parameters were
used from experimental measurement data.25,26 A pulsating
pressure was imposed in the lumen using the systolic/dia-
stolic arm pressure data for each patient at the time of the
MR imaging to perform patient-specific simulation. Pressure
at the out-boundary of each vessel slice was set to zero.
Definition and calculation of critical stress
Stress is the force acting on a surface divided by the area of
the surface. Stress can be ‘tensile’ or ‘structural stress’
when the force acts perpendicular to the surface, and
referred to as ‘biomechanical stress’ and ‘shear stress’
when the force is acting parallel to the endothelium
resulting from the viscous drag of the blood along the
arterial wall. Biomechanical stresses play a greater role in
plaque rupture compared with shear stress.27chaemic attack (TIA) patient at T1, proton density (PD) and STIR
t, which is hyperintense on T1, PD weighted MR images and
orted into ADINA 8.6 for biomechanical simulation. E shows the
que components (coloured) and at least <0.05 mm around the
ot showing the stress distribution in the plaque with M-CStress
Figure 2 Panel 1: A, B and C showing symptomatic plaque of a stroke patient at T1, PD and STIR weightings, L indicates lumen;
yellow star indicates fresh plaque haemorrhage, which is hyperintense on T1 and isointense on PD weighted and STIR weighted
image. D shows the fine mesh generated for simulations (mesh for plaque components are shown as coloured). E shows the band
plot showing the stress distribution in the plaque with M-CStress (maximum critical stress) at the vulnerable site which is plaque
shoulder and the minimum FC thickness site in the plaque. Panel 2: A, B and C showing symptomatic plaque of a TIA patient at T1,
PD and STIR weightings, L indicates lumen; yellow star indicates fresh plaque haemorrhage, which is hyperintense on T1 and
isointense on PD weighted and STIR weighted image. D shows the fine mesh generated for simulations (mesh for plaque components
are shown as coloured). E shows the band plot showing the stress distribution in the plaque with M-CStress (maximum critical stress)
at the vulnerable site (which is the plaque shoulder in this case). Panel 3: A, B and C showing symptomatic plaque of a recurrent TIA
patient at T1, PD and STIR weightings, L indicates lumen; yellow star indicates fresh PH, which is hyperintense on T1 and isointense
on PD and STIR weighted images. D shows the fine mesh generated for simulations (mesh for plaque components are shown as
coloured). E shows the band plot showing the stress distribution in the plaque with M-CStress (maximum critical stress) at the
vulnerable site which is the minimum thickness FC site.
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with normal vectors called principal directions, where
the corresponding stress vector is in the same direction as
the normal vector and there are no shear components. The
three stresses in the principle directions are called ‘prin-
cipal stresses’. The maximum principle stress (Stress-P1)
would be the maximum of the principle stresses and is used
to describe the stresses within the plaque. Critical stress
(M-CStress) was defined as the maximum of the maximum
principal stress (Stress-P1) values over the vulnerable site,
that is, minimum FC thickness or plaque shoulder.28 Healthy
regions where no plaque components were present and
rupture was unlikely were excluded from the analysis, even
if a high stress concentration occurred there. For each slice
within a plaque, Stress-P1 distribution corresponding to
peak-pressure condition was obtained from the 2D compu-
tational model. An automatic search was performed to find
M-CStress for each patient.Statistical analysis
The normality of the data was assessed by the ShapiroeWilk
normality test. Categorical variables were assessed by
Fischer’s exact test while continuous variables were
assessed using the ManneWhitney test. The level of
statistical significance was set to <0.05. All statistical
analysis was performed in GraphPad Instat (Version: 3.06).Results
The demographics and co-morbidities of the TIA, minor
stroke and asymptomatic groups are tabulated (Table 1).
Patients mostly had moderate luminal stenosis. M-CStress
of symptomatic plaques (n Z 45) was significantly higher
than in asymptomatic plaques (n Z 25) (median (inter-
quartile range (IQR): 275 kPa (190e390) vs. 165 kPa
Table 1 Demographics and co-morbidities of various patients groups.
TIA patients (1)
n Z 30
Stroke
patients (2)
n Z 15
Asymptomatic
patients (3)
N Z 25
P value
1 vs. 2 1 vs. 3 2 vs. 3
Age yrs median (interquartile range) 74 yrs (8) 76 yrs (68e81) 68 (56e76) 0.93 0.23 0.01
Hypertension n (%) 24 (53) 7 (16) 19 (76) 0.03 0.75 0.08
Diabetes n (%) 5 (11) 0 (0) 3 (12) 0.15 0.71 0.27
Peripheral vascular disease n (%) 4 (9) 2 (4) 5 (20) 1.00 0.71 0.69
Ischaemic heart disease n (%) 13 (29) 5 (11) 10 (40) 0.74 1.00 0.74
Aspirin n (%) 16 (36) 8 (18) 16 (64) 1.00 0.58 0.52
Statins n (%) 19 (42) 12 (27) 25 (100) 0.32 <0.005 <0.005
Clopidogrel n (%) 0 (0) 2 (4) 8 (32) 0.10 0.0009 0.26
Warfarin n (%) 2 (4) 3 (7) 1 (4) 0.31 1.00 0.13
Angiotensin converting
enzyme inhibitors n (%)
7 (16) 4 (19) 13 (52) 1.00 0.04 0.18
ECST % carotid stenosis median
(interquartile range)
54 (43e58) 52 (45e59) 52(46e59) 0.85 0.68 0.98
Systolic blood pressure
mmHg median (IQR)
138 (122e160) 140 (135e157) 133 (129e140) 0.58 0.19 0.07
Diastolic blood pressure
mmHg median (IQR)
77 (70e85) 80 (74e90) 72 (68e80) 0.32 0.35 0.11
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M-CStress differences were present between the TIA
(n Z 30) and stroke (n Z 15) patients (260 kPa (190e370)
vs. 295 kPa (200e510), p Z 0.31). Within the TIA patient
cohort, those who had presented with recurrent TIAs
(n Z 6) (Fig. 2, Panel 3) had significantly higher stresses
than patients who had suffered a single episode (n Z 24)
(425 kPa (285e580) vs. 250 kPa (180e310), pZ 0.001). The
number of recurrent TIAs in these six patients ranged from
two to six and had been ongoing for a variable duration (2
dayse3 months). Although stresses in recurrent TIA patients
were higher than those in stroke patients, they did not
reach the level of statistical significance (pZ 0.64). Within
the asymptomatic group (n Z 25), no M-CStress difference
was observed between true asymptomatic (n Z 13) and
previously symptomatic plaques (n Z 12) (165 kPa
(150e190) vs. 155 kPa (115e205), p Z 0.68). Fig. 3 gives
a graphical representation of these results.Figure 3 M-CStress of different clinical groups kPa [Median
(bar within the box) with interquartile ranges (upper and lower
limits of the box) and range (whiskers)] with p-value; symp-
tomatic (1) vs. asymptomatic patients (2), TIA (3) vs. stroke
group (4), single episode TIA (5) vs. recurrent TIAs group (6),
true asymptomatic (7) vs. previously asymptomatic (8).Discussion
This study demonstrates the utility of MR-imaging-based
biomechanical analysis to assess stress profiles of carotid
plaques in different clinical groups of patients with carotid
artery disease. We observed that symptomatic plaques had
significantly higher critical stresses than asymptomatic
plaques. It was also observed that plaques associated with
recurrent TIAs had significantly higher stresses than those
associated with a single episode of TIA. Previous studies
suggest that the higher the biomechanical stresses, the
greater the plaque vulnerability.16,29e32 Therefore, it can
be deduced from our results that symptomatic plaques are
more vulnerable than asymptomatic plaques. Furthermore,
recurrent TIA plaques have a greater vulnerability index
than those associated with single-episode TIA.
The pathomechanical explanation is that vulnerable pla-
ques develop weakening of plaque structure such as thinningof FCs33 due to greater underlying inflammatory activity.34
Repetitive loading of the weak structure leads to higher
mechanical stresses,35 increased material fatigue36 and,
ultimately, fracture (commonly known as rupture in the
medical field).13,37 The relationship between high athero-
sclerotic inflammatory activity and higher biomechanical
stresses has already been demonstrated by our group.35 Our
results are also in agreement with previously published
imaging studies, which showed that symptomatic carotid
plaques are more unstable than asymptomatic plaques,38
and so are the plaques associated with recurrent ischaemic
attacks compared with those associated with a single
event.39 Although TIA is globally considered a high-risk entity
which warrants urgent management, and the difference
88 U. Sadat et al.shown by this study between the single and recurrent TIA
groups may not alter clinical management, this study shows
the potential of biomechanical stress analysis in refining the
associated risk-stratification criteria.
It may be useful for identifying high-risk patients with
a lesser degree of carotid luminal stenosis, who may have
a higher risk of subsequent ischaemic events, but would not
be operated under present guidelines.40 This is because
luminal stenosis continues to be a gold standard for clinical
decision making for carotid interventions, although there is
evidence to suggest that non-severe stenotic lesions can
produce ischaemic syndromes41 and that plaque
morphology can provide pivotal information about plaque
vulnerability.42,43 Today, when there is a drive to offer
urgent carotid intervention to patients,2 even with
moderate stenosis,3 MR-imaging-based stress analysis may
prove beneficial to identify high-risk patients. Moreover,
this technique could help us adopt a different approach in
managing patients with a >70% stenosis and a single TIA but
a very low stress. These patients might, in the future,
against current guidelines, no longer be treated by revas-
cularisation but only by optimal medical treatment.
It can be observed from our results that there is an
overlap of stress values for the different subgroups. This
raises the question of whether biomechanical modelling
can provide cut-off values to differentiate various clinical
subgroups, which may be used for clinical decision making.
There is still considerable work that needs to be done to
achieve this goal. The reason is that the material properties
used for computational simulations are only an approxi-
mated representation of the actual material properties,
such as the assumption that the lipid core itself is a homo-
geneous region made up of lipid. In fact, this region
contains both esterified and unesterified cholesterol as well
as cellular debris in varying proportions among the pop-
ulation, thereby varying the material properties. Until
direct material properties for this region can be obtained,
such approximations will be used for simulations.44 There-
fore, a large database containing information about mate-
rial tests of various plaque constituents for various patient
subgroups needs to be established first and then used for
patient-specific simulations to enable a reliable cut-off
value to be put forward.
It was observed that all asymptomatic patients were on
a statin at the time of MR imaging, which they had been
taking for more than 3 months; however, only 68% of
symptomatic patients were taking a statin at the time of MR
imaging (which they had been on for more than 3 months).
Similarly, the use of anti-platelet medication and angio-
tensin-converting enzyme inhibitors was also higher in
asymptomatic patients than those who had presented with
TIA/stroke. This is something that could affect the results,
as these medications have the ability to stabilise the pla-
ques,45 potentially resulting in reduced stresses among
asymptomatic patients. A doseeresponse study using
various plaque-stabilising agents is warranted to assess
their impact on structural stability and structural stresses.
Other limitations of this study are: (1) Our sample size was
small with only six patients suffering recurrent TIAs;
nonetheless, important observations were made regarding
the stress profiles of various clinical groups, which justify
MR imaging studies with a larger sample size to confirmthese findings. (2) High-resolution MR imaging has the
inherent weakness of being less sensitive in identifying
calcification within plaques; therefore, we may have
underestimated the calcification and its biomechanical
effect in our simulations. Most likely this will be insignifi-
cant, as demonstrated by Huang et al.46 During simulations,
when calcification was eliminated and replaced with fibrous
plaque, stress changed insignificantly; the median increase
in stress was 0.1% (range, 0e8%; p Z 0.85), indicating that
calcification does not seem to decrease the mechanical
stability. (3) MR image comparison/co-registration was not
done, as we have validated this previously.47
Conclusions
MR-imaging-based biomechanical stress analysis can be
used for atheromatous plaque stress profiling of different
clinical groups of patients with carotid artery disease. It
can be used potentially for identification of high-risk
patients with vulnerable plaques, who may benefit from
urgent surgical interventions, as suggested by the UK
National Stroke Strategy. Whether the biomechanical
stresses within plaques are a cause or effect of plaque
vulnerability, and to what extent, remains to be answered;
this finding may be used for the development of biome-
chanics-based risk-stratification criteria for vulnerable
plaques in future.
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